TL13-112 is an anaplastic lymphoma kinase (ALK) Degrader. TL13-112 contains pomalidomide a celeblon ligand conjugated to an ALK inhibitor. This product is ready for conjugation to target proteins for PROTAC R&D. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.